Beximco Pharmaceuticals Limited (BXP.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 27.4B |
| Enterprise Value | 30.67B |
| P/E Ratio | 4.52 |
| PEG Ratio | 0.16 |
| Price/Sales Ratio | 0.72 |
| Price/Book Ratio | 0.65 |
| Enterprise/Revenue | 0.7 |
| Enterprise/EBITDA | 2.97 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.21 |
AD
Management Effectiveness
| Return On Assets | 0.11 |
| Return On Equity | 0.15 |
Income Statement
| Revenue | 49.12B |
| Revenue/Share | 119.83 |
| Gross Profit | 22.3B |
| EBITDA | 11.99B |
| Net Income | 6.94B |
| Diluted EPS | 15.56 |
Balance Sheet
| Total Cash | 5.15B |
| Total Cash/Share | 11.54 |
| Total Debt | 3.11B |
| Total Debt/Equity | 0.05 |
| Current Ratio | 4.13 |
| Book Value Per Share | 141.39 |
Price History
| 52-Week Change | 25 |
| 52-Week High | 65 |
| 52-Week Low | 0.43 |
| Moving Average 50 Days | 56.88 |
| Moving Average 200 Days | 24.64 |
Statistics
| Average Volume | 24,146 |
| Shares Outstanding | 446.11M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.83 |
| Trailing Annual Dividend Yield | 4.42 |
| Payout Ratio | 0.02 |
| Last Split Factor | 11:10 |
| Last Split Date | November 23, 2020 |
AD
